Multisystem inflammatory syndrome in children and Kawasaki disease : a critical comparison

© 2021. Springer Nature Limited..

Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are predominantly asymptomatic or have mild symptoms compared with the more severe coronavirus disease 2019 (COVID-19) described in adults. However, SARS-CoV-2 is also associated with a widely reported but poorly understood paediatric systemic vasculitis. This multisystem inflammatory syndrome in children (MIS-C) has features that overlap with myocarditis, toxic-shock syndrome and Kawasaki disease. Current evidence indicates that MIS-C is the result of an exaggerated innate and adaptive immune response, characterized by a cytokine storm, and that it is triggered by prior SARS-CoV-2 exposure. Epidemiological, clinical and immunological differences classify MIS-C as being distinct from Kawasaki disease. Differences include the age range, and the geographical and ethnic distribution of patients. MIS-C is associated with prominent gastrointestinal and cardiovascular system involvement, admission to intensive care unit, neutrophilia, lymphopenia, high levels of IFNγ and low counts of naive CD4+ T cells, with a high proportion of activated memory T cells. Further investigation of MIS-C will continue to enhance our understanding of similar conditions associated with a cytokine storm.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:17

Enthalten in:

Nature reviews. Rheumatology - 17(2021), 12 vom: 29. Dez., Seite 731-748

Sprache:

Englisch

Beteiligte Personen:

Sharma, Chetan [VerfasserIn]
Ganigara, Madhusudan [VerfasserIn]
Galeotti, Caroline [VerfasserIn]
Burns, Joseph [VerfasserIn]
Berganza, Fernando M [VerfasserIn]
Hayes, Denise A [VerfasserIn]
Singh-Grewal, Davinder [VerfasserIn]
Bharath, Suman [VerfasserIn]
Sajjan, Sujata [VerfasserIn]
Bayry, Jagadeesh [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Research Support, Non-U.S. Gov't
Review

Anmerkungen:

Date Completed 03.12.2021

Date Revised 28.10.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1038/s41584-021-00709-9

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM332547140